Anti-tumor necrosis factor alpha antibody in the treatment of Behçet's disease

Int Ophthalmol Clin. 2005 Spring;45(2):179-89. doi: 10.1097/01.iio.0000155901.41938.3c.
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Behcet Syndrome / drug therapy*
  • Behcet Syndrome / immunology
  • Female
  • Humans
  • Infliximab
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / immunology*
  • Visual Acuity

Substances

  • Antibodies, Monoclonal
  • Tumor Necrosis Factor-alpha
  • Infliximab